Mednet Logo
HomeMedical OncologyQuestion

Are there any differences in your approach to therapy for secondary versus primary myelofibrosis?

2
1 Answers
Mednet Member
Mednet Member
Medical Oncology · Massachusetts General Hospital

Good question. I will risk stratify patients with secondary MF using the MYSEC-PM score and primary MF patients using DIPSS+ or MIPSS. Anecdotally, patients with secondary MF tend to have more indolent MF and there is definitely a grey zone period when you know they are transforming but still doing ...

Register or Sign In to see full answer

Are there any differences in your approach to therapy for secondary versus primary myelofibrosis? | Mednet